COVID-19 and dexamethasone-induced hyperglycaemia: Workload implications for diabetes inpatient teams

Diabet Med. 2022 Feb;39(2):e14716. doi: 10.1111/dme.14716. Epub 2021 Oct 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • COVID-19 / blood
  • COVID-19 / epidemiology
  • COVID-19 Drug Treatment*
  • Comorbidity
  • Dexamethasone / adverse effects*
  • Dexamethasone / therapeutic use
  • Diabetes Mellitus / epidemiology*
  • Female
  • Humans
  • Hyperglycemia / chemically induced*
  • Inpatients
  • Male
  • Middle Aged
  • Patient Care Team / statistics & numerical data
  • SARS-CoV-2*
  • Workload / statistics & numerical data*

Substances

  • Dexamethasone